Floatz logo

ACETIC ACID, SODIUM SALT (1:1)

Endocrine System Diseases

University Hospital, Basel, SwitzerlandSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Endocrine System Diseases cohort.

Asset / SponsorPhaseRating
Hcg
Merck KGaA, Darmstadt, Germany
Phase 3BB
TESTOSTERONE UNDECYLATE
Craig Hospital
Phase 4BB
Follitropin Alpha
Merck KGaA, Darmstadt, Germany
Phase 3BB
Irinotecan
Xiaoxiang Chen
Phase 2BB
Msj-0011
Merck KGaA, Darmstadt, Germany
Phase 3BB

View all 27 →

Same molecule, other indications

ACETIC ACID, SODIUM SALT (1:1) is also rated in:

GliomasDormant
B
Indicative ·
57 / 100
View asset →
Stroke, AcuteDormant
B
Indicative ·
57 / 100
View asset →
Prostate AdenocarcinomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →